Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: Evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test

被引:32
|
作者
Barbalho, Cilene Aparecida [1 ,2 ]
Nunes-de-Souza, Ricardo L. [3 ]
Canto-de-Souza, Azair [1 ]
机构
[1] Univ Fed Sao Carlos, CECH, Dept Psicol, Grp Psicobiol, BR-13565905 Sao Carlos, SP, Brazil
[2] Univ Fed Sao Carlos, CCBS, PPG CF, BR-13565905 Sao Carlos, SP, Brazil
[3] Univ Estadual Paulista UNESP, Fac Ciencias Farmaceut, Farmacol Lab, BR-14801902 Araraquara, Brazil
关键词
Anxiety; Maze-naive and maze-experienced mouse; Midazolam; Flumazenil; DMCM; Amygdala; ONE-TRIAL TOLERANCE; PERIAQUEDUCTAL GRAY; ANIMAL-MODELS; DEFENSIVE BEHAVIOR; RAT BEHAVIOR; ANXIETY; FLUMAZENIL; AMYGDALA; EXPERIENCE; CHLORDIAZEPOXIDE;
D O I
10.1016/j.brainres.2009.02.042
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies have demonstrated that microinjections of midazolam, a benzodiazepine receptor agonist, into the amygdala produce anxiolytic-like effects in elevated plus-maze (EPM)-naive rodents. However, systemic or intracerebral administration of benzodiazepines (BDZ) fails to alter anxiety in maze-experienced animals, a phenomenon defined as "one trial tolerance" (OTT). This study focused on the effects of intra-amygdala infusion of midazolam in maze-experienced mice. In addition, the effects of flumazenil in the amygdala of maze-naive and experienced mice were also investigated. To investigate intrinsic effects of intra-amygdala flumazenil on anxiety, animals were systemically treated with the BDZ receptor inverse agonist, DMCM (4-ethyl-6,7-dimethoxy-9H-pyrido[3,4-b] indole-3-carboxylic acid methyl ester hydrochloride). Conventional measures of anxiety (% open arm entries and % open arm time), locomotor activity (frequency of closed arm entries) and a range of ethological measures related to risk assessment were recorded. Intra-amygdala midazolam (3.0 and 30 nmol) attenuated anxiety in maze-experienced mice. A similar behavioral profile was produced by intra-amygdala flumazenil in maze-naive (4.0 and 16 nmol) and maze-experienced (16 nmol) mice. Intra-amygdala flumazenil (at 2.0 nmol, a dose devoid of any intrinsic effect on anxiety measures in the EPM) selectively and completely blocked the anxiogenic-like effects of systemic administration of DMCM (1.0 mg/kg, i.p.) in maze-naive mice. Together, these results demonstrate that the GABA(A)-benzodiazepine receptor complex located within the amygdala does not play a role in the OTT phenomenon. Present results also suggest that the release of an endogenous BDZ receptor inverse agonist within the amygdala seems to be an important correlate of the emotional state induced by the plus-maze test. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:65 / 76
页数:12
相关论文
共 8 条
  • [1] EFFECTS OF BENZODIAZEPINE RECEPTOR ANTAGONIST, FLUMAZENIL, ON ANTINOCICEPTIVE AND BEHAVIORAL-RESPONSES TO THE ELEVATED PLUS-MAZE IN MICE
    LEE, C
    RODGERS, RJ
    NEUROPHARMACOLOGY, 1991, 30 (12A) : 1263 - 1267
  • [2] EFFECTS OF BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONISTS IN THE ELEVATED PLUS-MAZE TEST OF ANXIETY IN THE RAT
    COLE, BJ
    HILLMANN, M
    SEIDELMANN, D
    KLEWER, M
    JONES, GH
    PSYCHOPHARMACOLOGY, 1995, 121 (01) : 118 - 126
  • [3] NICOTINIC RECEPTOR AGONISTS EXHIBIT ANXIOLYTIC-LIKE EFFECTS ON THE ELEVATED PLUS-MAZE TEST
    BRIONI, JD
    ONEILL, AB
    KIM, DJB
    DECKER, MW
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 238 (01) : 1 - 8
  • [4] 'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze
    Rodgers, RJ
    Haller, J
    Halasz, J
    Mikics, E
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 17 (06) : 1279 - 1286
  • [5] The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze
    Rodgers, RJ
    Gentsch, C
    Hoyer, D
    Bryant, E
    Green, AJ
    Kolokotroni, KZ
    Martin, JL
    BEHAVIOURAL BRAIN RESEARCH, 2004, 154 (01) : 183 - 192
  • [6] ANXIOLYTIC-LIKE EFFECT OF (S)-WAY-100135, A 5-HT1A RECEPTOR ANTAGONIST, IN THE MURINE ELEVATED PLUS-MAZE TEST
    RODGERS, RJ
    COLE, JC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 261 (03) : 321 - 325
  • [7] Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests
    Jastrzebska-Wiesek, Magdalena
    Siwek, Agata
    Partyka, Anna
    Kubacka, Monika
    Mogilski, Szczepan
    Wasik, Anna
    Kolaczkowski, Marcin
    Wesolowska, Anna
    NEUROPHARMACOLOGY, 2014, 85 : 253 - 262
  • [8] Anxiolytic-Like Effects of 7H-Benzo[e]perimidin-7-One Derivatives through Elevated Plus-Maze Test in Mice
    Nunez, Jorge
    Fontenla, Jose A.
    Nabavi, Seyed Mohammad
    Uriarte, Eugenio
    Herrera, Alejandra
    Sobarzo-Sanchez, Eduardo
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (17) : 1750 - 1754